Endothelium and vascular smooth muscle cells in the context of uremia

Seminars in Dialysis

Volumn 22, Issue 4, 2009, Pages 428-432

  Günthner, Thomas ^a   Jankowski, Vera ^a   Kretschmer, Axel ^b   Nierhaus, Marc ^a   Van Der Giet, Markus ^a   Zidek, Walter ^a   Jankowski, Joachim ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b BAYER PHARMA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATHEROSCLEROSIS; HUMAN; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SMOOTH MUSCLE FIBER; UREMIA; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ATHEROSCLEROSIS; ENDOTHELIUM, VASCULAR; HUMANS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; UREMIA;

EID: 69249104918     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2009.00594.x     Document Type: Article

References (34)

1. Vanholder R, Massy Z, Argiles A, Spasovski G, Verbeke F, Lameire N : Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant 20 : 1048 1056, 2005
2. Collins AJ, Kasiske B, Herzog C, Chavers B, Foley R, Gilbertson D, Grimm R, Liu J, Louis T, Manning W, Matas A, McBean M, Murray A, St Peter W, Xue J, Fan Q, Guo H, Li S, Roberts T, Snyder J, Solid C, Wang C, Weinhandl E, Arko C, Chen SC, Dalleska F, Daniels F, Dunning S, Ebben J, Frazier E, Johnson R, Sheets D, Forrest B, Berrini D, Constantini E, Everson S, Frederick P, Eggers P, Agodoa L : Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States. Am J Kidney Dis 45 : A5 A7, 2005
3. Vanholder R, De Smet R, Glorieux G, Argiles A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, Descamps-Latscha B, Henle T, Jorres A, Lemke HD, Massy ZA, Passlick-Deetjen J, Rodriguez M, Stegmayr B, Stenvinkel P, Tetta C, Wanner C, Zidek W : Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 63 : 1934 1943, 2003
4. Jacobi J, Porst M, Cordasic N, Namer B, Schmieder RE, Eckardt KU, Hilgers KF : Subtotal nephrectomy impairs ischemia-induced angiogenesis and hindlimb re-perfusion in rats. Kidney Int 69 : 2013 2021, 2006
5. Baylis C : Arginine, arginine analogs and nitric oxide production in chronic kidney disease. Nat Clin Pract Nephrol 2 : 209 220, 2006
6. Passauer J, Pistrosch F, Bussemaker E, Lassig G, Herbrig K, Gross P : Reduced agonist-induced endothelium-dependent vasodilation in uremia is attributable to an impairment of vascular nitric oxide. J Am Soc Nephrol 16 : 959 965, 2005
7. Mallamaci F, Tripepi G, Cutrupi S, Malatino LS, Zoccali C : Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD. Kidney Int 67 : 2330 2337, 2005
8. Unger T : The role of the renin-angiotensin system in the development of cardiovascular disease. Am J Cardiol 89 : 3A 9A (discussion 10A 2002
9. Kim JA, Berliner JA, Nadler JL : Angiotensin II increases monocyte binding to endothelial cells. Biochem Biophys Res Commun 226 : 862 868, 1996
10. Kubo A, Fukuda N, Soma M, Izumi Y, Kanmatsuse K : Inhibitory effect of an angiotensin II type 1 receptor antagonist on growth of vascular smooth muscle cells from spontaneously hypertensive rats. J Cardiovasc Pharmacol 27 : 58 63, 1996
11. Yanagitani Y, Rakugi H, Okamura A, Moriguchi K, Takiuchi S, Ohishi M, Suzuki K, Higaki J, Ogihara T : Angiotensin II type 1 receptor-mediated peroxide production in human macrophages. Hypertension 33 : 335 339, 1999
12. Mann JF, Schmieder RE, McQueen M, Dyal L, Schumacher H, Pogue J, Wang X, Maggioni A, Budaj A, Chaithiraphan S, Dickstein K, Keltai M, Metsarinne K, Oto A, Parkhomenko A, Piegas LS, Svendsen TL, Teo KK, Yusuf S : Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet 372 : 547 553, 2008
13. Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C : Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 358 : 1547 1559, 2008
14. Konidala S, Gutterman DD : Coronary vasospasm and the regulation of coronary blood flow. Prog Cardiovasc Dis 46 : 349 373, 2004
15. Campbell DJ : The renin-angiotensin and the kallikrein-kinin systems. Int J Biochem Cell Biol 35 : 784 791, 2003
16. Eto T : A review of the biological properties and clinical implications of adrenomedullin and proadrenomedullin N-terminal 20 peptide (PAMP), hypotensive and vasodilating peptides. Peptides 22 : 1693 1711, 2001
17. Vanholder R, Van Laecke S, Glorieux G : What is new in uremic toxicity? Pediatr Nephrol 23 : 1211 1221, 2008
18. Guidolin D, Albertin G, Spinazzi R, Sorato E, Mascarin A, Cavallo D, Antonello M, Ribatti D : Adrenomedullin stimulates angiogenic response in cultured human vascular endothelial cells: involvement of the vascular endothelial growth factor receptor 2. Peptides 29 : 2013 2023, 2008
19. Kaysen GA, Eiserich JP : The role of oxidative stress-altered lipoprotein structure and function and microinflammation on cardiovascular risk in patients with minor renal dysfunction. J Am Soc Nephrol 15 : 538 548, 2004
20. Serradell M, Diaz-Ricart M, Cases A, Zurbano MJ, Lopez-Pedret J, Arranz O, Ordinas A, Escolar G : Uremic medium causes expression, redistribution and shedding of adhesion molecules in cultured endothelial cells. Haematologica 87 : 1053 1061, 2002
21. Trevisan R, Dodesini AR, Lepore G : Lipids and renal disease. J Am Soc Nephrol 17 : S145 S147, 2006
22. Kielstein JT, Impraim B, Simmel S, Bode-Boger SM, Tsikas D, Frolich JC, Hoeper MM, Haller H, Fliser D : Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans. Circulation 109 : 172 177, 2004 (Pubitemid 38114135)
23. Cooke JP : Asymmetrical dimethylarginine: the Uber marker? Circulation 109 : 1813 1818, 2004
24. Matsuguma K, Ueda S, Yamagishi S, Matsumoto Y, Kaneyuki U, Shibata R, Fujimura T, Matsuoka H, Kimoto M, Kato S, Imaizumi T, Okuda S : Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease. J Am Soc Nephrol 17 : 2176 2183, 2006
25. Kielstein JT, Fliser D : The past, presence and future of ADMA in nephrology. Nephrol Ther 3 : 47 54, 2007
26. Yamamoto H, Tsuruoka S, Ioka T, Ando H, Ito C, Akimoto T, Fujimura A, Asano Y, Kusano E : Indoxyl sulfate stimulates proliferation of rat vascular smooth muscle cells. Kidney Int 69 : 1780 1785, 2006
27. Dou L, Jourde-Chiche N, Faure V, Cerini C, Berland Y, Dignat-George F, Brunet P : The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells. J Thromb Haemost 5 : 1302 1308, 2007
28. Anagnostoulis S, Karayiannakis AJ, Lambropoulou M, Efthimiadou A, Polychronidis A, Simopoulos C : Human leptin induces angiogenesis in vivo. Cytokine 42 : 353 357, 2008
29. Jankowski J, Hagemann J, Yoon MS, van der Giet M, Stephan N, Zidek W, Schluter H, Tepel M : Increased vascular growth in hemodialysis patients induced by platelet-derived diadenosine polyphosphates. Kidney Int 59 : 1134 1141, 2001
30. Jankowski V, Günthner T, Herget-Rosenthal S, Zidek W, Jankowski J : Dinucleoside polyphosphates and uremia. Semin Dial 22 : 396 399, 2009
31. Jankowski V, Meyer AA, Schlattmann P, Gui Y, Zheng XL, Stamcou I, Radtke K, Tran TN, van der Giet M, Tolle M, Zidek W, Jankowski J : Increased uridine adenosine tetraphosphate concentrations in plasma of juvenile hypertensives. Arterioscler Thromb Vasc Biol 27 : 1776 1781, 2007
32. Erlinge D : Extracellular ATP: a growth factor for vascular smooth muscle cells. Gen Pharmacol 31 : 1 8, 1998 (Pubitemid 28239746)
33. Tsai MY, Arnett DK, Eckfeldt JH, Williams RR, Ellison RC : Plasma homocysteine and its association with carotid intimal-medial wall thickness and prevalent coronary heart disease: NHLBI Family Heart Study. Atherosclerosis 151 : 519 524, 2000
34. Walcher D, Babiak C, Poletek P, Rosenkranz S, Bach H, Betz S, Durst R, Grub M, Hombach V, Strong J, Marx N : C-Peptide induces vascular smooth muscle cell proliferation: involvement of SRC-kinase, phosphatidylinositol 3-kinase, and extracellular signal-regulated kinase 1/2. Circ Res 99 : 1181 1187, 2006